Results for tag: "Familial Mediterranean Fever Drug"

The Familial Mediterranean Fever Drug market is a subset of the Immune Disorders Drugs market. It is composed of drugs used to treat Familial Mediterranean Fever (FMF), a genetic disorder characterized by recurrent episodes of fever and inflammation. Common drugs used to treat FMF include colchicine, an anti-inflammatory drug, and anakinra, an interleukin-1 receptor antagonist. These drugs are used to reduce the frequency and severity of FMF attacks, as well as to reduce the risk of amyloidosis, a serious complication of FMF. The Familial Mediterranean Fever Drug market is highly competitive, with several major pharmaceutical companies offering products. These include AbbVie, Amgen, Sanofi, and Pfizer. Other companies in the market include Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more